Matt T. Rosenberg, MD Director, MidMichigan Health Centers, Jackson, MI
Roger R. Dmochowski, MD Department of Urologic Surgery, Vanderbilt University School of Medicine, Nashville, TN
Address: Matt T. Rosenberg, MD, Director, MidMichigan Health Centers, 214 N. West Avenue, Jackson, MI 49201; e-mail matttoren@yahoo.com
Dr. Rosenberg has indicated that he is on the speakers’ bureau of Watson, Pfizer, and Ortho-McNeil, is a consultant for Pfizer and Ortho-McNeil, and has received grant or research support from Ortho-McNeil.
Dr. Dmochowski has indicated that he is a consultant for Watson and Indevus.
This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTPrimary care physicians must initiate a discussion of overactive bladder and urinary incontinence with their patients who are at risk. A stepwise approach to evaluation and diagnosis and the use of systematic evaluation and treatment algorithms suitable to the primary care setting will improve identification and effective management of the incontinent patient.
